About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Antidepressant Incomplete Response Depression | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00782964

Antidepressant Incomplete Response Depression

Observational, non-interventional, longitudinal, prospective,multicenter, open label (No treatment is involved). 3 assessment will be carried out . The 1st one will be on baseline, the 2sd one after a...

Lead sponsor: AstraZeneca•48 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

AstraZeneca

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Provision of written inform consent
•Diagnosed of Major Depressive Disorder based on DSM-IV-TR
•Outpatient who has a change in pharmacological therapeutic plan after an incomplete response or intolerance to a treatment with an adequate dosage of an antidepressant (SSRI/NSRI) 5
•Able to understand and to comply with requirements of the study

Exclusion Criteria

•Mental retardation
•To have been recruited in a clinical trial in the last 4 weeks or to have planned the inclusion in a clinical trial during the follow-up of this study
•MDD secondary to substance abuse or somatic illness
•Actual depressive episode with \<4 weeks or \>12 months of length
•Current treatment with \>1 SSRI/SRNI or previous treatment with \>1 SSRI/SRNI, augmentation treatment with SSRI/SRNI, intravenous antidepressant treatment, TMS, ECT or MAO

Related studies

RECRUITINGPhase 3

Ketamine Augmentation of ECT in Treatment-Resistant Depression

NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression

RECRUITINGPhase 2

Lemborexant for the Treatment of Residual Insomnia in Major Depressive Disorder (MDD)

NCT06843187 · Major Depressive Disorder(MDD), Insomnia Comorbid to Psychiatric Disorder

RECRUITINGPhase 3

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

NCT06564818 · Major Depressive Disorder

RESISTance Exercise for Depression Trial

NCT06110897 · Major Depressive Disorder

RECRUITINGPhase 1/2

Neural Response to Inflammatory Challenge in Major Depressive Disorder

NCT04751331 · Major Depressive Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 24, 2009Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment364

Start dateOct 2008

Last updatedDec 24, 2009

Condition

Major Depressive Disorder

Locations shown

Research Site

Albacete, Albacete

Research Site

Alcoy, Alicante

Research Site

Benidorm, Alicante

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 24, 2009Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions